Company / Total Assets
Tvardi Therapeutics, Inc. Total Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$43.8M
FY2024
5-year range
$43.8M / $271.2M
FY2020-FY2024
Trend
-65.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 4 consecutive years, from $271M in FY2020 to $44M in FY2024.
Based on SEC 10-K filings.
$44M in FY2024 with a 5-year CAGR of -28.4%.
Declined from $182M to $44M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -43.8%
- 5-Year CAGR
- -28.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Tvardi Therapeutics, Inc.'s total assets has declined for 4 consecutive years.
- 5-year CAGR of -28.4%, indicating a declining trend.
- In FY2024, total assets decreased 65.2% year-over-year.
- Peak total assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $43.8M | -65.2% |
| FY2023 | $125.8M | -30.9% |
| FY2022 | $182.2M | -26.2% |
| FY2021 | $247.1M | -8.9% |
| FY2020 | $271.2M | +16.4% |
| FY2019 | $233.0M | +22.1% |
| FY2018 | $190.8M | +96.7% |
| FY2017 | $97.0M | +52.0% |
| FY2016 | $63.8M | -42.4% |
| FY2015 | $110.9M | +98.3% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026